Lactose Quarterly Results for Trading Insights

LACTOSE • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹5 Cr
QMarch 2025
Quarterly Results

Lactose Quarterly Results Key Highlights

  • Revenue of ₹118 Cr in March 2025 (+0.0% vs March 2025, +2.6% vs March 2024)
  • Net Profit of ₹5 Cr in March 2025 (+0.0% vs March 2025, -28.6% vs March 2024)
  • EBITDA of ₹18 Cr in March 2025 (+0.0% vs March 2025)
  • Operating Margin of 15.0% in March 2025 (+0.0pp vs March 2025)
  • Earnings Per Share of ₹4.10 in March 2025 (+0.0% vs March 2025)

Lactose Quarterly Results Analysis

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 139 118 115 67 47 17.8% -
Net Profit (₹ Cr) 5 5 7 1 3 - -
EBITDA (₹ Cr) 18 18 20 12 13 - -
EPS (₹) 3.60 4.10 5.39 0.96 2.10 - -
Operating Margin (%) 12.0% 15.0% 17.0% 17.0% 27.0% - -

Lactose Share Price Trend Around Quarterly Results

Visualize Lactose's 1-year price movement across quarterly results — ideal for logging trades in Lactose share price chart using Tickjournal. All values in ₹.

Profitability Ratios

Profit Margin 4.2%
EBITDA Margin 15.3%
Operating Margin 15.0%
ROE (Annual) 8.5%

Balance Sheet Highlights

Total Assets ₹134 Cr
Total Equity ₹59 Cr
Current Assets ₹57 Cr
Current Liabilities ₹30 Cr

Cash Flow Analysis

Operating Cash Flow ₹0 Cr
Investing Cash Flow ₹-16 Cr
Financing Cash Flow ₹19 Cr
Net Cash Flow ₹3 Cr

Current Market Data

Current Price ₹104.25
Exchange BSE
Last Updated Jan 06, 2026

Sector Competitors - Quarterly Performance Comparison

Comparing Lactose quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025
₹422,330.94 Cr 1760.2 14,875 3,125 +10.8% - 21.0% 135.4
Divis Laboratories
Sept 2025
₹176,337.50 Cr 6642.5 2,860 689 +7.1% - 24.1% 255.8
Torrent Pharmaceuti…
Sept 2025
₹136,522.12 Cr 3936.8 3,219 591 +11.3% - 18.4% 224.4
Cipla
Sept 2025
₹121,238.47 Cr 1530.8 7,716 1,353 +12.0% - 17.5% 91.5
Dr Reddys Laborator…
Sept 2025
₹104,829.57 Cr 1256.2 9,135 1,337 +1.1% - 14.6% 77.6
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores